• Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

CombTher_Adobe_photoguns_portrait
Read more
© photoguns
  • Digital Health

Navigating the Landscape of Digital Health – United Kingdom

Healthcare_Adobe_elenabsl
Read more

2021 OHE Annual Report to the Charity Commission

charityreport_lina-trochez-unsplash_landscape
Read more
© Lina Trochez/Unsplash

Supporting the Era of Green Pharmaceuticals in the UK

Sustainability_AdobeStock_270582392_landscape
Read more

Quality of life and wellbeing in individuals with experience of fertility problems and assisted reproductive techniques

Quality of life assisted reproduction Cover
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

gene_therapies_national-cancer-institute-unsplash_landscape
Read more
© NCI/Unsplash
  • Drug Development/R&D
  • Economics of Innovation
  • Health Policy and Regulation

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

CBO-US_mayer-tawfik-K4Ckc0AxgDI-unsplash_landscape
Read more
© Mayer Tawfik/Unsplash
  • Measuring and Valuing Outcomes

When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies

PROMS_unsplash_National Cancer Institute_landscape
Read more
© NCI/Unsplash
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 5th October 2016

OHE is pleased to appoint two Senior Visiting Fellows: Professor David Parkin and Professor Lou Garrison

OHE is pleased to announce the appointment of two new Senior Visiting Fellows: Professor David Parkin and Professor Lou Garrison. OHE is pleased to announce the appointment of its first two Senior Visiting Fellows: Professor David Parkin and Professor Lou…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email

OHE is pleased to announce the appointment of two new Senior Visiting Fellows: Professor David Parkin and Professor Lou Garrison.

OHE is pleased to announce the appointment of its first two Senior Visiting Fellows: Professor David Parkin and Professor Lou Garrison. These appointments stem from Dave and Lou’s significant contributions to OHE’s programme of research over recent years, and plans for future collaborations. The OHE is pleased to formally recognise these valuable working relationships.

Professor David Parkin is a well-known and highly experienced researcher. He has been involved in a number of OHE Research projects over recent years including:

  • Assessing the performance of the EQ-VAS in the NHS PROMs programme
  • What Determines the Shape of an EQ-5D Index Distribution?
  • The Influence of Cost-effectiveness and Other Factors on NICE Decisions
  • Adjusting Patient Case Mix to Compare PROMs across Providers

Dave brings considerable experience in a number of methods and topic areas that are a good match with OHE’s key themes and programmes of work:

  • Econometric analysis (cross sectional and panel data)
  • Health state valuation methods
  • Efficiency analysis (e.g data envelopment analysis)
  • Survival analysis/hazard function estimation
  • Cost effectiveness thresholds.

Dave is a collaborative investigator on a number of projects that are either underway (such as New methods for analysing the distribution of EQ-5D data in patient samples) or currently being planned to including an analysis of the impact of waiting times targets in the English NHS and Guidance on analysing EQ-5D data.

OHE’s Director of Research, Professor Nancy Devlin, said of the appointment: “We are delighted that Dave has accepted this role with OHE and look forward to working closely with him. Dave’s depth of experience in health economics research will further add to the work OHE is doing on health related quality of life, cost effectiveness thresholds, efficiency analyses and many other topics.”

Professor Lou Garrison is an extremely well-respected health economist; his economic expertise, industry experience and policy understanding has been valuable on numerous OHE Research and OHE Consulting projects over the last decade. He recently stepped down from his full time Professorship at the University of Washington but remains on the faculty. He is currently President of ISPOR and co-chair of ISPOR’s Special Task Force on US Value Frameworks.

Lou has contributed to projects across at least three of OHE’s six research programmes: Incentives, reimbursement, behaviours and performance; Drug development & accelerated access; Stratified medicine. Lou has co-authored numerous articles and consulting reports with OHE staff on topics around these three programmes. These include:

  • Personalised Medicine: Economic Incentives for Evidence Generation
  • Risk-Sharing Agreements Between Pharmaceutical Manufacturers and Payers
  • Personalised Medicine and the Value of Molecular Diagnostics
  • Governance models for real-world evidence
  • The Expanding Value Footprint of Oncology Treatments

Lou is also named as a collaborator on ongoing OHE Consulting and Research projects.

OHE’s Director, Professor Adrian Towse, commented: “It is great to have a formal continuing link with Lou following his earlier sabbatical year with us. His energy, expertise, and ideas will provide great support to our team, notably on his key interests in personalised medicine, value assessment, real world evidence, and health systems in middle and low income countries.”

Related News

Group 11119
  • News
  • February 2023

Applications open for MSc Fellowship Programme 2023

Read more
Prize event
  • News
  • January 2023

Professor Aidan Hollis wins first £40,000 OHE Policy Innovation Prize

Read more
  • News
  • July 2022

OHE is Leading Research to Develop an EQ-5D ‘Bolt-on’ for Hearing

Read more
MicrosoftTeams-image-6_0
  • News
  • June 2022

OHE’s 60th Anniversary Party – Celebrating Our Achievements and Looking Forward

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!